Student Profile - Kieren Marr
EMBA Class of
Kieren Marr is a professor of medicine at Johns Hopkins University, where she serves as director of transplant and oncology infectious diseases and vice chair for innovation in healthcare implementation in the Department of Medicine. She works on technology and healthcare implementation improvements. She also founded MycoMed Technologies, a JHU spin-off company focused on commercializing in vitro diagnostics and personalized technologies to prevent infections. She is vice president of the honor society for physician-scientists, the American Society for Clinical Investigation, and in 2015 was voted “One of the World’s Most Influential Scientific Minds” by Thomson Reuters.
Why This Program?
I’ve been in academic medicine for 25 years and have grown to appreciate the need to have a better understanding of organizational management and how to get products to patients. MIT’s EMBA program was a tremendous opportunity to learn skillsets that are very applicable to my leadership positions in academic medicine. I was especially interested MIT’s focus on the science of management and evidence derived from a quantitative, research-driven approach. In addition, the flexible schedule enables me to integrate learning through hands-on applications of that knowledge in my job. All these attributes are unique to MIT Sloan’s EMBA Program.